Julie Devallière

1.2k citations

22 papers · 972 indexed · h-index 16

Impact in

Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications

Papers in

Transplantation 2
Biomaterials 7
- Electrospun Nanofibers in Biomedical Applications 4
- Nanoparticle-Based Drug Delivery 3

Co-authors: Béatrice Charreau Basak E. Uygun Martin L. Yarmush Thibaut Quillard Kevin Dooley Stéphanie Coupel Jordan S. Pober Parwiz Abrahimi
Journals: Biochemical Pharmacology (3 papers)Biomaterials (2 papers)The FASEB Journal (2 papers)PLoS ONE (2 papers)Drug Delivery and Translational Research (1 paper)
Partner nations: France United States Italy

In The Last Decade

Julie Devallière

22 papers receiving 967 citations

Peers

Countries citing papers authored by Julie Devallière

Since Specialization

Citations

This map shows the geographic impact of Julie Devallière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Devallière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Devallière more than expected).

Fields of papers citing papers by Julie Devallière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Devallière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Devallière. The network helps show where Julie Devallière may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Julie Devallière, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julie Devallière Line = papers co-authored together Julie Devallière links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages Drug Delivery and Translational Research ·汪崇金, Clément Anfray, José Crecente‐Campo, Akihiro Maeda, Aldo Ummarino, Jean-Claude. Auteur du texte Favre, 信之葉波, 박남용 조현, Laurence Poul, Julie Devallière, Matthieu Germain, Juan Correa, Marcos Fernandez‐Villamarin, Paola Allavena, Eduardo Fernández-Megía, Marı́a José Alonso, Fernando Torres	2022	20
2	A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA Nano Letters ·Nell Saunders, H.-J. Bücker König, Owen S. Fenton, Laurence Poul, Julie Devallière, 박남용 조현, Audrey Darmon, Rafael Wilmer Contreras Urgiles, Tariq zeyad Al-Nasser, Matthieu Germain, Róbert Langer	2020	72
3	Tissue scaffolds functionalized with therapeutic elastin‐like biopolymer particles Biotechnology and Bioengineering ·Beyza Bulutoglu, Julie Devallière, 敏男三島, Aylin Acun, 大竹誠, Basak E. Uygun, Martin L. Yarmush	2020	9
4	Repopulation of intrahepatic bile ducts in engineered rat liver grafts PubMed ·Yibin Chen, Julie Devallière, Beyza Bulutoglu, Martin L. Yarmush, Basak E. Uygun	2019	16
5	Abstract 3613: Mononuclear phagocytic system occupancy to increase nanomedicines based treatment efficacy Cancer Research ·Matthieu Germain, Laurence Poul, Julie Devallière, H.-J. Bücker König, Audrey Darmon, Rafael Wilmer Contreras Urgiles, Tariq zeyad Al-Nasser, 박남용 조현	2019	2
6	Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain Acta Biomaterialia ·Julie Devallière, Yibin Chen, Kevin Dooley, Martin L. Yarmush, Basak E. Uygun	2018	63
7	Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice Biomaterials ·Julie Devallière, Kevin Dooley, Yong Hu, 大竹誠, Basak E. Uygun, Martin L. Yarmush	2017	88
8	Liposome-based Formulation for Intracellular Delivery of Functional Proteins Molecular Therapy — Nucleic Acids ·Babatunde Agbaje, Mathieu Mével, Julie Devallière, Pedro Mario González Jiménez, Thomas Haudebourg, Peter Caneppele, Thibault Colombani, Mathieu Berchel, Olivier Lambert, Aleksander Edelman, Bruno Pitard	2015	104
9	The disintegrin and metalloproteinase ADAM10 mediates a canonical Notch-dependent regulation of IL-6 through Dll4 in human endothelial cells Biochemical Pharmacology ·Byung Kyu Park, Julie Devallière, Thibaut Quillard, Flora Coulon, Nathalie Gérard, Christian Laboisse, Claire Toquet, Béatrice Charreau	2014	17
10	Differential Roles of Hath1, MUC2 and P27Kip1 in Relation with Gamma-Secretase Inhibition in Human Colonic Carcinomas: A Translational Study PLoS ONE ·Frédérique Souazé, Chantal Bou‐Hanna, Adriana S. Forseto, T. A. Ilchishina, Julie Devallière, Béatrice Charreau, Stéphane Bezieau, Jean‐François Mosnier, Christian Laboisse	2013	5
11	Paracrine exchanges of molecular signals between alginate-encapsulated pericytes and freely suspended endothelial cells within a 3D protein gel Biomaterials ·Jillian W. Andrejecsk, Jiajia Cui, William Chang, Julie Devallière, Jordan S. Pober, W. Mark Saltzman	2013	21
12	Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-κB Signaling in Endothelial Cells Circulation ·Dan Jane‐wit, Thomas D. Manes, Tai Yi, Lingfeng Qin, Pamela Clark, Nancy C. Kirkiles-Smith, Parwiz Abrahimi, Julie Devallière, Gilbert Moeckel, Sanjay Kulkarni, George Tellides, Jordan S. Pober	2013	109
13	Profiling Posttransplant Circulating Antibodies in Kidney Transplantation Using Donor Endothelial Cells Transplantation ·Emmanuel Canet, Julie Devallière, Nathalie Gérard, George A. Karam, Magali Giral, Béatrice Charreau, Stéphanie Coupel	2012	13
14	LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α‐parvin to control cell adhesion and migration The FASEB Journal ·Julie Devallière, Mathias Chatelais, 脩二西浜, Nathalie Gérard, Philippe Hulin, Laura Evelia Torres Velázquez, Christopher E. Turner, Béatrice Charreau	2012	36
15	Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft’s cytoprotection Xenotransplantation ·Mathias Chatelais, Julie Devallière, Cesare Galli, Béatrice Charreau	2011	14
16	The adaptor Lnk (SH2B3): An emerging regulator in vascular cells and a link between immune and inflammatory signaling Biochemical Pharmacology ·Julie Devallière, Béatrice Charreau	2011	95
17	Xenotransplantation of Galactosyl-Transferase Knockout, CD55, CD59, CD39, and Fucosyl-Transferase Transgenic Pig Kidneys Into Baboons Transplantation Proceedings ·Stéphanie Le Bas‐Bernardet, X. Tillou, Nicolas Poirier, Nahzli Dilek, Mathias Chatelais, Julie Devallière, Béatrice Charreau, David Minault, Jérémy Hervouet, Karine Renaudin, Claire Crossan, Linda Scobie, Peter J. Cowan, A. J. F. D'Apice, Cesare Galli, Emanuele Cozzi, Jean‐Paul Soulillou, Bernard Vanhove, Gilles Blancho	2011	52
18	Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases American Journal of Physiology-Cell Physiology ·Christophe Guitton, Alice Cottereau, Nathalie Gérard, Thibaut Quillard, Bill J.C Pangayow, Julie Devallière, Pierre Tonnerre, Béatrice Charreau	2011	25
19	Inflammation dysregulates Notch signaling in endothelial cells: Implication of Notch2 and Notch4 to endothelial dysfunction Biochemical Pharmacology ·Thibaut Quillard, Julie Devallière, Stéphanie Coupel, Béatrice Charreau	2010	77
20	Notch2 Signaling Sensitizes Endothelial Cells to Apoptosis by Negatively Regulating the Key Protective Molecule Survivin PLoS ONE ·Thibaut Quillard, Julie Devallière, Mathias Chatelais, Flora Coulon, Céline Séveno, Mathilde Romagnoli, Sophie Barillé‐Nion, Béatrice Charreau	2009	55

About Julie Devallière

Julie Devallière is a scholar working on Transplantation, Biomaterials, Immunology and Allergy, Rehabilitation and Orthopedics and Sports Medicine, having authored 22 papers that have together received 972 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (4 papers), Virus-based gene therapy research (3 papers), Tissue Engineering and Regenerative Medicine (3 papers), RNA Interference and Gene Delivery (3 papers), Wound Healing and Treatments (3 papers), Tendon Structure and Treatment (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Transplantation (78 citations), Biomaterials (199 citations), Rehabilitation (84 citations), Immunology (198 citations) and Molecular Biology (414 citations). Julie Devallière has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Béatrice Charreau, Basak E. Uygun, Martin L. Yarmush, Thibaut Quillard, Kevin Dooley, Stéphanie Coupel, Jordan S. Pober, Parwiz Abrahimi, Mathias Chatelais and Dan Jane‐wit. Their work appears in journals such as Biochemical Pharmacology, Biomaterials, The FASEB Journal, PLoS ONE and Drug Delivery and Translational Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact